Standout Papers
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis (2008)
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis (2012)
- Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients (2006)
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis (2021)
- Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis (2025)
Immediate Impact
3 by Nobel laureates 9 from Science/Nature 111 standout
Citing Papers
Multiple sclerosis
2023 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Works of Robert J. Fox being referenced
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
2021
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert J. Fox | 7728 | 2721 | 2166 | 2525 | 307 | 12.4k | |
| Bruce Cree | 8026 | 3431 | 1727 | 2658 | 275 | 12.5k | |
| Alasdair Coles | 8899 | 3232 | 2679 | 3735 | 193 | 13.1k | |
| Gianluigi Mancardi | 5069 | 3122 | 1719 | 2367 | 316 | 14.0k | |
| Elliot M. Frohman | 8487 | 3314 | 1628 | 2417 | 248 | 14.8k | |
| D. A. S. Compston | 7573 | 4215 | 1921 | 3467 | 179 | 13.3k | |
| Olaf Stüve | 6191 | 2543 | 2364 | 3303 | 248 | 11.2k | |
| Peter Rieckmann | 6616 | 2812 | 2308 | 3060 | 261 | 12.8k | |
| Wallace W. Tourtellotte | 8453 | 4013 | 1753 | 2908 | 152 | 15.9k | |
| Robert P. Lisak | 4719 | 4409 | 1355 | 2605 | 304 | 11.7k | |
| Carlo Pozzilli | 9882 | 4046 | 1991 | 1645 | 376 | 14.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...